Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons I.C. (Isabelle) van Gelder

Publicaties

Asundexian versus Apixaban in Patients with Atrial Fibrillation

Atrial arrhythmia and heart failure in congenital heart disease: A pas de deux with consequences

Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association

Determinants and impact of postoperative atrial fibrillation burden during 2.5 years of continuous rhythm monitoring after cardiac surgery: Results from the RACE V prospective cohort study

Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study

Hospital healthcare utilisation in patients with atrial fibrillation: the role of multimorbidity and age

Multimorbidity approaches in elderly patients with atrial fibrillation. The upcoming EHRA-PATHS project

Multimorbidity increases risk of cardiovascular outcomes in permanent atrial fibrillation: Data from the RACE II study

Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation— Data From the RACE V Study

The ‘ten commandments' for the 2024 European Society of Cardiology guidelines on atrial fibrillation

Pers/media

Hart op hol, geen paniek.